FDA approves first generic Atacand

News
Article

Sandoz has become the first company to gain the FDA approval to produce a generic version of Atacand (candesartan cilexetil).

Sandoz has become the first company to gain the FDA approval to produce a generic version of Atacand (candesartan cilexetil), the popular heart drug that generated an estimated 120 million in domestic sales last year.

“Sandoz is proud to be the first generic company to market this important generic treatment option to patients in the U.S.,” said Don DeGolyer, president of Sandoz US. “The launch of candesartan further expands our offering of high-quality, affordable cardiology medicines.”

Candesartan cilexetil tablets are used to treat heart failure in some adults and hypertension in adults and children 1 to 17 years of age.  

Sandoz’s generic candesartan cilexetil tablets will be available in 4-mg, 8-mg, 16-mg, and 32-mg strength tablets.

 

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
© 2025 MJH Life Sciences

All rights reserved.